Sprint Bioscience AB (5JA1)
Munich
0.2800
0.00 (0.00%)
Closed
Aug 25, 2026
Day's Range
0.28000.2800
52 wk Range
0.05020.4030
Financial Statements - 5JA1 - Sprint Bioscience AB
Revenue
167.16M▲ 154.7%
Net Income
91.73M▲ 601.9%Net Margin 54.9%
EBITDA
93.23M▲ 639.6%
Free Cash Flow
83.43M▲ 438.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 167.16M | 65.64M | 50.48M | 35.11M | 16.88M | 33.54M |
| Cost of Goods | 13.07M | 28.33M | 8.69M | 10.43M | 10.45M | 8.17M |
| Gross Profit | 154.08M | 37.30M | 41.78M | 24.67M | 6.42M | 25.36M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 97.54M | -19.40M | -845K | -25.46M | -37.67M | -20.42M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 91.73M | -18.27M | -438K | -25.08M | -42.79M | -21.53M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | - |
| Net Income | 91.73M | -18.27M | -438K | -25.08M | -42.79M | -21.53M |
| EPS Basic | 0.99 | -0.245873 | -0.01 | -0.723455 | -2.289522 | -1.55634 |
| EPS Diluted | 0.98 | -0.245873 | -0.01 | -0.723455 | -2.289522 | -1.55634 |
| Basic Shares Outstanding | 92.60M | 73.83M | 781.20M | 387.78M | 208.94M | 154.91M |
| Diluted Shares Outstanding | 92.60M | 73.83M | 781.20M | 387.78M | 208.94M | 154.91M |
| Ebit | 92.16M | -18.23M | -51K | -24.81M | -39.35M | -20.32M |
| Ebitda | 93.23M | -17.27M | 396K | -24.22M | -38.65M | -19.59M |
| Net Income Continuous Operations | 97.29M | -19.66M | -845K | -25.62M | -37.84M | -20.24M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
